OrthoPediatrics (FRA:2X7) Tariff Resilience Score: 5/10 (As of Jul. 11, 2026)


FRA:2X7 OrthoPediatrics Corp FRA:2X7
77 GF Score
Price €17.50
GF Value €27.58
! 5 Warning Signs
View Full Analysis

What is OrthoPediatrics Tariff Resilience Score?

OrthoPediatrics FRA:2X7 +7.36% 77 Tariff Resilience Score is 5 as of Jul. 11, 2026. GuruFocus rates FRA:2X7 with a GF Score™ of 77/100 and a GF Value™ of €27.58. The stock has 5 warning signs investors should review. Among 835 Medical Devices & Instruments companies, OrthoPediatrics ranks better than 79.16% on this metric.

OrthoPediatrics has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

OrthoPediatrics has OrthoPediatrics relies on international suppliers for medical devices, exposing it to tariff risks. While the healthcare sector can sometimes secure exemptions, the company's limited pricing power and dependency on specific markets increase vulnerability.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes OrthoPediatrics might have Average Resilient.

OrthoPediatrics  (FRA:2X7) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

OrthoPediatrics Tariff Resilience Score Related Terms

FRA:2X7 vs PACB, CLPT, MOBI: Tariff Resilience Score Comparison

For the Medical Devices subindustry, OrthoPediatrics's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OrthoPediatrics Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OrthoPediatrics's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where OrthoPediatrics's Tariff Resilience Score falls into.


FRA:2X7
77GF Score
OrthoPediatrics Corp FRA:2X7
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
OrthoPediatrics (FRA:2X7) has a Tariff Resilience Score of 5 as of Jul. 11, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, OrthoPediatrics ranks #174 out of 835 companies in the Medical Devices & Instruments industry, placing it in the top 20.8%.
Is OrthoPediatrics' Tariff Resilience Score too high?
OrthoPediatrics' current Tariff Resilience Score is 5. Based on the distribution chart, OrthoPediatrics ranks #174 out of 835 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, OrthoPediatrics has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does OrthoPediatrics' Tariff Resilience Score compare to PACB and CLPT?
According to the Medical Devices & Instruments industry distribution chart, OrthoPediatrics ranks #174 out of 835 companies for Tariff Resilience Score. This places OrthoPediatrics in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. OrthoPediatrics's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrthoPediatrics stock overvalued right now?
OrthoPediatrics (FRA:2X7) has a current Tariff Resilience Score of 5. The stock's GF Value™ is €27.58, compared to a current price of €17.50 — trading 36.5% below its estimated fair value. The current Tariff Resilience Score is 5. OrthoPediatrics' overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For OrthoPediatrics (FRA:2X7), the current Tariff Resilience Score is 5 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OrthoPediatrics (FRA:2X7) Overvalued in 2026?

Based on GuruFocus' analysis, OrthoPediatrics stock appears to be undervalued. The current stock price of €17.50 is trading 36.5% below its estimated GF Value™ of €27.58.

Key valuation signals for FRA:2X7:

  • Tariff Resilience Score: 5
  • GF Value™: €27.58 vs. price of €17.50 (36.5% below fair value)
  • GF Score™: 77/100 with 5 warning signs

No single metric tells the full story. See the FRA:2X7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OrthoPediatrics Business Description

Other Exchanges KIDS:USA
Address 2850 Frontier Drive, Warsaw, IN, USA, 46582
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.
77GF Score

Get the complete analysis for FRA:2X7

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.50
Price
€27.58
GF Value